SRPT — 4 insiders, all selling

Form 4 lag: insiders have 2 business days to file after a trade (weekends and holidays extend this), and this site re-ingests once daily — a transaction can appear here roughly three business days after it happened.
13F lag: quarterly 13F-HR holdings cover the prior quarter-end and are due 45 days after it — every institutional position shown here is at least 45 days old by construction, often more.
CUSIP→ticker gaps: 13F positions are reported by CUSIP; some holdings cannot be matched to a current ticker (delistings, corporate actions, thin metadata) and appear without one or are omitted from ticker-level views.
EDGAR timing variability: institutions file at different hours and days within their windows; amended filings (4/A, 13F-HR/A) can restate earlier periods, so historical aggregates may change between batches.

Sarepta Therapeutics, Inc. · Materials · ISO week 2026-W36 (2026-09-04 → 2026-09-04)

WATCH − all sells routine-only window · clu-5b5c2517621a · detected 2026-09-09

4Distinct insiders

4Transactions

−$1.8MTotal reported value

4Source filings

Members

Insider	Role	Txns	Reported value
Estepan Ian Michael	Chief Operating Officer	1	$551k
Rothfuss Cristin	EVP, General Counsel	1	$489k
Rodino-Klapac Louise	President, R&D and Tech Ops	1	$476k
Wong Ryan Ho-Yan	Chief Financial Officer	1	$295k

− Estepan Ian Michael Chief Operating Officer F routine 24,799 sh @ $22.22 = $551k 0001193125-26-385544
− Rothfuss Cristin EVP, General Counsel F routine 22,025 sh @ $22.22 = $489k 0001193125-26-385541
− Rodino-Klapac Louise President, R&D and Tech Ops F routine 21,423 sh @ $22.22 = $476k 0001193125-26-385536
− Wong Ryan Ho-Yan Chief Financial Officer F routine 13,272 sh @ $22.22 = $295k 0001193125-26-385545